Location
Switzerland, Europe
Cheque size
$100K - $5M
Investment Stage
Seed
Series A
Series B
Focus Areas
AI
BioTech
About Investor
Therese Liechtenstein is an Investment Director at M Ventures (Merck), the strategic CVC arm of Merck. She invests primarily in biotech and therapeutics, and is explicitly tied to early-stage therapeutics (e.g., oncology and immunology) while also spanning AI/tech adjacency as relevant to Merck’s remit. Her listed investment range is $100K – $5.0M (sweet spot $1.5M). Background-wise, she previously led strategic projects for Merck’s healthcare business, and her academic track includes a PhD in Immuno-Oncology.
Previous investments
DISCO Pharmaceuticals
22M |2024
Anavo Therapeutics
9M |2023
24M |2021
Altoida
14M |2022
Similar Investors
JG
Joaquin Gomez
United Kingdom, Europe
$50K - $1M
Pre Seed
,Seed
,WT
William Tunstall-Pedoe
United Kingdom, Europe
$10K - $500K
Pre Seed
,Seed
,CJ
Christoph Janz
Germany, Europe
$580K - $3.5M
Pre Seed
,Seed
,IT
Igor Tikhturov
United Kingdom, Europe
$100K - $5M
Pre Seed
,Seed
,EV
Eze Vidra
United Kingdom, Europe
$300K - $1.5M
Pre Seed
,Seed
,PL
Pierre-Eric Leibovici
France, Europe
$500K - $10M
Seed
,Series A
,Is this Your Profile?
If you have any updates, please fill out our form.